Sima Lev - Publications

Affiliations: 
Molecular Cell Biology Weizmann Institute of Science, Rehovot, Israel 
Area:
Molecular Biology, Microbiology Biology

67 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Gil-Henn H, Girault JA, Lev S. PYK2, a hub of signaling networks in breast cancer progression. Trends in Cell Biology. PMID 37586982 DOI: 10.1016/j.tcb.2023.07.006  0.669
2022 Nataraj NB, Noronha A, Lee JS, Ghosh S, Mohan Raju HR, Sekar A, Zuckerman B, Lindzen M, Tarcitano E, Srivastava S, Selitrennik M, Livneh I, Drago-Garcia D, Rueda O, Caldas C, Lev S, et al. Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors. Cell Reports. 38: 110418. PMID 35196484 DOI: 10.1016/j.celrep.2022.110418  0.787
2022 Müller AK, Köhler UA, Trzebanski S, Vinik Y, Raj HM, Girault JA, Ben-Chetrit N, Maraver A, Jung S, Lev S. Mouse Modeling Dissecting Macrophage-Breast Cancer Communication Uncovered Roles of PYK2 in Macrophage Recruitment and Breast Tumorigenesis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2105696. PMID 35092356 DOI: 10.1002/advs.202105696  0.644
2021 Castellanet O, Ahmad F, Vinik Y, Mills GB, Habermann B, Borg JP, Lev S, Lamballe F, Maina F. BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulators. Theranostics. 11: 9180-9197. PMID 34646365 DOI: 10.7150/thno.60503  0.714
2021 Khera L, Lev S. Accelerating AXL targeting for TNBC therapy. The International Journal of Biochemistry & Cell Biology. 106057. PMID 34403827 DOI: 10.1016/j.biocel.2021.106057  0.659
2021 Khera L, Vinik Y, Maina F, Lev S. The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC. Life Science Alliance. 4. PMID 33785524 DOI: 10.26508/lsa.202000985  0.659
2021 Lamballe F, Ahmad F, Vinik Y, Castellanet O, Daian F, Müller AK, Köhler UA, Bailly AL, Josselin E, Castellano R, Cayrou C, Charafe-Jauffret E, Mills GB, Géli V, Borg JP, Lev S, et al. Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 8: 2003049. PMID 33552868 DOI: 10.1002/advs.202003049  0.696
2020 Vinik Y, Ortega FG, Mills GB, Lu Y, Jurkowicz M, Halperin S, Aharoni M, Gutman M, Lev S. Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response. Science Advances. 6. PMID 33008904 DOI: 10.1126/sciadv.aba5714  0.671
2020 Verma N, Vinik Y, Saroha A, Nair NU, Ruppin E, Mills G, Karn T, Dubey V, Khera L, Raj H, Maina F, Lev S. Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis. Science Advances. 6. PMID 32937365 DOI: 10.1126/Sciadv.Aba8968  0.79
2020 Shatz-Azoulay H, Vinik Y, Isaac R, Kohler U, Lev S, Zick Y. The Animal Lectin Galectin-8 Promotes Cytokine Expression and Metastatic Tumor Growth in Mice. Scientific Reports. 10: 7375. PMID 32355198 DOI: 10.1038/S41598-020-64371-Z  0.628
2020 Lev S. Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis. Biochemical Society Transactions. 48: 657-665. PMID 32311020 DOI: 10.1042/BST20191055  0.653
2020 Verma N, Müller AK, Kothari C, Panayotopoulou E, Kedan A, Selitrennik M, Mills GB, Nguyen LK, Shin S, Karn T, Holtrich U, Lev S. Correction: Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis. Cancer Research. 80: 362. PMID 31941679 DOI: 10.1158/0008-5472.CAN-19-3573  0.745
2019 Peretti D, Kim S, Tufi R, Lev S. Lipid Transfer Proteins and Membrane Contact Sites in Human Cancer. Frontiers in Cell and Developmental Biology. 7: 371. PMID 32039198 DOI: 10.3389/Fcell.2019.00371  0.796
2019 Keinan O, Kedan A, Gavert N, Selitrennik M, Kim S, Karn T, Becker S, Lev S. Correction: The lipid-transfer protein Nir2 enhances epithelial-mesenchymal transition and facilitates breast cancer metastasis (doi:10.1242/jcs.155721). Journal of Cell Science. 132. PMID 30846603 DOI: 10.1242/Jcs.227868  0.756
2018 Kedan A, Verma N, Saroha A, Shreberk-Shaked M, Müller AK, Nair NU, Lev S. PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein. Cell Death & Disease. 9: 985. PMID 30250159 DOI: 10.1038/S41419-018-1005-Z  0.811
2018 Shin SY, Müller AK, Verma N, Lev S, Nguyen LK. Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer. Plos Computational Biology. 14: e1006192. PMID 29920512 DOI: 10.1371/Journal.Pcbi.1006192  0.806
2017 Panayotopoulou EG, Müller AK, Börries M, Busch H, Hu G, Lev S. Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells. Oncotarget. PMID 28187446 DOI: 10.18632/oncotarget.15125  0.795
2016 Yu J, Lei R, Zhuang X, Li X, Li G, Lev S, Segura MF, Zhang X, Hu G. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nature Communications. 7: 13884. PMID 27996004 DOI: 10.1038/ncomms13884  0.638
2016 Verma N, Müller AK, Kothari C, Panayotopoulou E, Kedan A, Selitrennik M, Mills GB, Nguyen LK, Shin S, Karn T, Holtrich U, Lev S. Targeting of PYK2 synergizes with EGFR antagonists in basal-like TNBC and circumvents HER3-associated resistance via the NEDD4-NDRG1 axis. Cancer Research. PMID 27793840 DOI: 10.1158/0008-5472.Can-16-1797  0.78
2016 Selitrennik M, Lev S. The role of phosphatidylinositol-transfer proteins at membrane contact sites. Biochemical Society Transactions. 44: 419-24. PMID 27068949 DOI: 10.1042/BST20150182  0.805
2015 Selitrennik M, Lev S. PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop. Oncotarget. 6: 22214-26. PMID 26084289 DOI: 10.18632/oncotarget.4257  0.81
2015 Verma N, Keinan O, Selitrennik M, Karn T, Filipits M, Lev S. PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition. Nature Communications. 6: 6064. PMID 25648557 DOI: 10.1038/Ncomms7064  0.798
2014 Keinan O, Kedan A, Gavert N, Selitrennik M, Kim S, Karn T, Becker S, Lev S. The lipid-transfer protein Nir2 enhances epithelial-mesenchymal transition and facilitates breast cancer metastasis. Journal of Cell Science. 127: 4740-9. PMID 25179602 DOI: 10.1242/Jcs.155721  0.772
2014 Hong W, Lev S. Tethering the assembly of SNARE complexes. Trends in Cell Biology. 24: 35-43. PMID 24119662 DOI: 10.1016/j.tcb.2013.09.006  0.65
2013 Kim S, Kedan A, Marom M, Gavert N, Keinan O, Selitrennik M, Laufman O, Lev S. The phosphatidylinositol-transfer protein Nir2 binds phosphatidic acid and positively regulates phosphoinositide signalling. Embo Reports. 14: 891-9. PMID 23897088 DOI: 10.1038/Embor.2013.113  0.758
2013 Laufman O, Freeze HH, Hong W, Lev S. Deficiency of the Cog8 subunit in normal and CDG-derived cells impairs the assembly of the COG and Golgi SNARE complexes. Traffic (Copenhagen, Denmark). 14: 1065-77. PMID 23865579 DOI: 10.1111/Tra.12093  0.777
2013 Laufman O, Hong W, Lev S. The COG complex interacts with multiple Golgi SNAREs and enhances fusogenic assembly of SNARE complexes. Journal of Cell Science. 126: 1506-16. PMID 23378023 DOI: 10.1242/Jcs.122101  0.783
2012 Rao M, Song W, Jiang A, Shyr Y, Lev S, Greenstein D, Brantley-Sieders D, Chen J. VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity. Plos One. 7: e46281. PMID 23049696 DOI: 10.1371/Journal.Pone.0046281  0.66
2012 Lev S. Nonvesicular lipid transfer from the endoplasmic reticulum. Cold Spring Harbor Perspectives in Biology. 4. PMID 23028121 DOI: 10.1101/cshperspect.a013300  0.633
2011 Laufman O, Hong W, Lev S. The COG complex interacts directly with Syntaxin 6 and positively regulates endosome-to-TGN retrograde transport. The Journal of Cell Biology. 194: 459-72. PMID 21807881 DOI: 10.1083/Jcb.201102045  0.793
2010 Lev S. Non-vesicular lipid transport by lipid-transfer proteins and beyond. Nature Reviews. Molecular Cell Biology. 11: 739-50. PMID 20823909 DOI: 10.1038/nrm2971  0.631
2010 Kim S, Leal SS, Ben Halevy D, Gomes CM, Lev S. Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated VAP-B(P56S) neurotoxicity. The Journal of Biological Chemistry. 285: 13839-49. PMID 20207736 DOI: 10.1074/Jbc.M109.097345  0.775
2009 Laufman O, Kedan A, Hong W, Lev S. Direct interaction between the COG complex and the SM protein, Sly1, is required for Golgi SNARE pairing. The Embo Journal. 28: 2006-17. PMID 19536132 DOI: 10.1038/Emboj.2009.168  0.778
2008 Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, Sultana H, Brass AL, Adametz R, Tsui M, Qian F, Montgomery RR, Lev S, Mason PW, Koski RA, Elledge SJ, et al. RNA interference screen for human genes associated with West Nile virus infection. Nature. 455: 242-5. PMID 18690214 DOI: 10.1038/Nature07207  0.605
2008 Peretti D, Dahan N, Shimoni E, Hirschberg K, Lev S. Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport. Molecular Biology of the Cell. 19: 3871-84. PMID 18614794 DOI: 10.1091/Mbc.E08-05-0498  0.793
2008 Lev S, Ben Halevy D, Peretti D, Dahan N. The VAP protein family: from cellular functions to motor neuron disease. Trends in Cell Biology. 18: 282-90. PMID 18468439 DOI: 10.1016/J.Tcb.2008.03.006  0.776
2006 Lev S. Lipid homoeostasis and Golgi secretory function Biochemical Society Transactions. 34: 363-366. PMID 16709162 DOI: 10.1042/BST0340363  0.645
2005 Litvak V, Dahan N, Ramachandran S, Sabanay H, Lev S. Maintenance of the diacylglycerol level in the Golgi apparatus by the Nir2 protein is critical for Golgi secretory function. Nature Cell Biology. 7: 225-34. PMID 15723057 DOI: 10.1038/Ncb1221  0.804
2005 Amarilio R, Ramachandran S, Sabanay H, Lev S. Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. The Journal of Biological Chemistry. 280: 5934-44. PMID 15545272 DOI: 10.1074/jbc.M409566200  0.632
2005 Corvol JC, Valjent E, Toutant M, Enslen H, Irinopoulou T, Lev S, Hervé D, Girault JA. Depolarization activates ERK and proline-rich tyrosine kinase 2 (PYK2) independently in different cellular compartments in hippocampal slices. The Journal of Biological Chemistry. 280: 660-8. PMID 15537634 DOI: 10.1074/jbc.M411312200  0.653
2004 Rolls A, Avidan H, Cahalon L, Schori H, Bakalash S, Litvak V, Lev S, Lider O, Schwartz M. A disaccharide derived from chondroitin sulphate proteoglycan promotes central nervous system repair in rats and mice. The European Journal of Neuroscience. 20: 1973-83. PMID 15450076 DOI: 10.1111/J.1460-9568.2004.03676.X  0.704
2004 Lev S. The role of the Nir/rdgB protein family in membrane trafficking and cytoskeleton remodeling. Experimental Cell Research. 297: 1-10. PMID 15194420 DOI: 10.1016/j.yexcr.2004.02.033  0.649
2004 Litvak V, Argov R, Dahan N, Ramachandran S, Amarilio R, Shainskaya A, Lev S. Mitotic phosphorylation of the peripheral Golgi protein Nir2 by Cdk1 provides a docking mechanism for Plk1 and affects cytokinesis completion. Molecular Cell. 14: 319-30. PMID 15125835 DOI: 10.1016/S1097-2765(04)00214-X  0.796
2003 Rubin C, Litvak V, Medvedovsky H, Zwang Y, Lev S, Yarden Y. Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops. Current Biology : Cb. 13: 297-307. PMID 12593795 DOI: 10.1016/S0960-9822(03)00053-8  0.81
2002 Litvak V, Shaul YD, Shulewitz M, Amarilio R, Carmon S, Lev S. Targeting of Nir2 to lipid droplets is regulated by a specific threonine residue within its PI-transfer domain. Current Biology : Cb. 12: 1513-8. PMID 12225667 DOI: 10.1016/S0960-9822(02)01107-7  0.743
2002 Litvak V, Tian D, Carmon S, Lev S. Nir2, a human homolog of Drosophila melanogaster retinal degeneration B protein, is essential for cytokinesis. Molecular and Cellular Biology. 22: 5064-75. PMID 12077336 DOI: 10.1128/Mcb.22.14.5064-5075.2002  0.751
2002 Tian D, Lev S. Cellular and developmental distribution of human homologues of the Drosophilia rdgB protein in the rat retina. Investigative Ophthalmology & Visual Science. 43: 1946-53. PMID 12037004  0.566
2002 Tian D, Litvak V, Toledo-Rodriguez M, Carmon S, Lev S. Nir2, a novel regulator of cell morphogenesis. Molecular and Cellular Biology. 22: 2650-62. PMID 11909959 DOI: 10.1128/Mcb.22.8.2650-2662.2002  0.744
2001 Lev S. Molecular aspects of retinal degenerative diseases Cellular and Molecular Neurobiology. 21: 575-589. PMID 12043834 DOI: 10.1023/A:1015183500719  0.558
2000 Tian D, Litvak V, Lev S. Cerebral ischemia and seizures induce tyrosine phosphorylation of PYK2 in neurons and microglial cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 6478-87. PMID 10964954 DOI: 10.1523/Jneurosci.20-17-06478.2000  0.731
2000 Litvak V, Tian D, Shaul YD, Lev S. Targeting of PYK2 to focal adhesions as a cellular mechanism for convergence between integrins and G protein-coupled receptor signaling cascades. The Journal of Biological Chemistry. 275: 32736-46. PMID 10915788 DOI: 10.1074/Jbc.M004200200  0.766
2000 Ling S, Woronuk G, Sy L, Lev S, Braun AP. Enhanced activity of a large conductance, calcium-sensitive K+ channel in the presence of Src tyrosine kinase. The Journal of Biological Chemistry. 275: 30683-9. PMID 10893418 DOI: 10.1074/Jbc.M004292200  0.608
1996 Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature. 383: 547-50. PMID 8849729 DOI: 10.1038/383547A0  0.785
1996 Tokiwa G, Dikic I, Lev S, Schlessinger J. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science (New York, N.Y.). 273: 792-4. PMID 8670418 DOI: 10.1126/Science.273.5276.792  0.783
1995 Blechman JM, Lev S, Barg J, Eisenstein M, Vaks B, Vogel Z, Givol D, Yarden Y.. The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell. 80: 103-113. PMID 7529140 DOI: 10.1016/0092-8674(95)90455-7  0.747
1994 Lev S, Blechman JM, Givol D, Yarden Y. Steel factor and c-kit protooncogene: Genetic lessons in signal transduction Critical Reviews in Oncogenesis. 5: 141-168. PMID 7531500 DOI: 10.1615/Critrevoncog.V5.I2-3.30  0.658
1994 Lev S, Blechman JM, Givol D, Yarden Y.. Steel factor and c-kit protooncogene: genetic lessons in signal transduction. Crit Rev Oncog.. 5: 141-68. PMID 7531500 DOI: 10.1615/critrevoncog.v5.i2-3.30  0.777
1993 Blechman JM, Lev S, Givol D, Yarden Y.. Structure-function analyses of the kit receptor for the steel factor. Stem Cells.. 12-21. PMID 7691317 DOI: 10.1002/stem.5530110804  0.755
1993 Blechman JM, Lev S, Givol D, Yarden Y. Structure-function analyses of the Kit receptor for the steel factor Stem Cells. 11: 12-21. PMID 7691317 DOI: 10.1002/Stem.5530110804  0.623
1993 Lev S, Blechman J, Nishikawa S, Givol D, Yarden Y.. Interspecies molecular chimeras of kit help define the binding site of the stem cell factor. Mol Cell Biol.. 13: 2224-34.. PMID 7681144 DOI: 10.1128/mcb.13.4.2224  0.731
1992 Lev S, Yarden Y, Givol D. Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor Journal of Biological Chemistry. 267: 15970-15977. PMID 1379243  0.624
1992 Lev S, Yarden Y, Givol D. A recombinant ectodomain of the receptor for the Stem Cell Factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses Journal of Biological Chemistry. 267: 10866-10873. PMID 1375232  0.63
1992 Lev S, Givol D, Yarden Y. Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase Proceedings of the National Academy of Sciences of the United States of America. 89: 678-682. PMID 1370584 DOI: 10.1073/Pnas.89.2.678  0.648
1992 Lev S, Givol D, Yarden Y.. Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase. Proc Natl Acad Sci U S a.. 89: 678-82. PMID 1370584 DOI: 10.1073/pnas.89.2.678  0.771
1991 Lev S, Givol D, Yarden Y. A specific combination of substrates is involved in signal transduction by the kit-encoded receptor Embo Journal. 10: 647-654. PMID 1705885 DOI: 10.1002/J.1460-2075.1991.Tb07993.X  0.77
1990 Lev S, Yarden Y, Givol D.. Receptor functions and ligand-dependent transforming potential of a chimeric kit proto-oncogene. Mol Cell Biol.. 10: 6064-8.. PMID 1700279 DOI: 10.1128/mcb.10.11.6064  0.762
1990 Lev S, Yarden Y, Givol D. Receptor functions and ligand-dependent transforming potential of a chimeric kit proto-oncogene Molecular and Cellular Biology. 10: 6064-6068. PMID 1700279 DOI: 10.1128/Mcb.10.11.6064  0.632
Show low-probability matches.